Pure Global
NCT06347445

Turkish Nationwide SurvEy of Glycemic and Other Metabolic Parameters of Patients With Diabetes Mellitus-2 (TEMD-2 Study)

Gulhane School of Medicine·ClinicalTrials.gov·otherCompleted
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Diabetes Mellitus
Drug/Device/Intervention
There is no intervention.
Study type
Observational
Intervention type
other
Sponsor & location
Primary sponsor
Gulhane School of Medicine
Location
Ankara, Turkey
Timeline & enrollment
Phase
N/A
Start date
Oct 01, 2022
End date
Jan 30, 2023
Enrollment
5707 participants
Primary outcome

Glycemia control status of Turkish adult patients with diabetes mellitus,Blood pressure control status of Turkish adult patients with diabetes mellitus,Lipid control status of Turkish adult patients with diabetes mellitus.,Weight control status of Turkish adult patients with diabetes mellitus.

Summary

This study evaluates the metabolic control status, cardiovascular risk and frequency of
 comorbidities in diabetic patients followed in tertiary treatment centers in Turkey.

ICD-10 classifications
Diabetes mellitusUnspecified diabetes mellitusOther specified diabetes mellitusUnspecified diabetes mellitus without complicationsUnspecified diabetes mellitus with unspecified complications
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06347445
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06347445 through Pure Global AI's free database. This phase not specified trial is sponsored by Gulhane School of Medicine and is currently Completed. The study focuses on Diabetes Mellitus. Target enrollment is 5707 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.